Arterra Bioscience S.p.A. (BIT:ARBS)
Italy · Delayed Price · Currency is EUR 2.600
+0.080 (3.17%)
Aug 12, 2025, 5:56 PM CET
ShockWave Medical Market Cap
Arterra Bioscience has a market cap or net worth of €17.31 million as of August 13, 2025. Its market cap has increased by 30.00% in one year.
Market Cap
17.31M
Enterprise Value
14.33M
Revenue
4.17M
Ranking
n/a
PE Ratio
12.95
Stock Price
$2.60
Market Cap Chart
Since October 28, 2019, Arterra Bioscience's market cap has decreased from 22.33M to 17.31M, a decrease of -22.46%. That is a compound annual growth rate of -4.30%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 17.31M | 32.65% |
| Dec 30, 2024 | 13.05M | 18.07% |
| Dec 29, 2023 | 11.05M | -23.15% |
| Dec 30, 2022 | 14.38M | -24.57% |
| Dec 30, 2021 | 19.07M | 1.75% |
| Dec 30, 2020 | 18.74M | -24.46% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Oct 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Recordati Industria Chimica e Farmaceutica | 10.26B |
| DiaSorin | 4.47B |
| Amplifon | 3.38B |
| EL.En. | 957.03M |
| Philogen | 859.07M |
| Safilo Group | 523.60M |
| GPI S.p.A. | 473.19M |
| Pharmanutra | 458.55M |